Tempus ECG-Low EF vs TeraRecon Cardiovascular.Calcification.CT
AI Verdict
Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if you need a rapid, non-invasive screening tool to identify patients 40 years or older at risk of heart failure directly from a standard 12-lead ECG. This is ideal for primary care, emergency departments, or internal medicine settings to flag individuals for further cardiac evaluation, such as an echocardiogram, based on an easily accessible test.
View Tempus ECG-Low EF →Choose TeraRecon Cardiovascular.Calcification.CT if…
Choose TeraRecon Cardiovascular.Calcification.CT if you require precise, automated quantification of coronary artery calcification from CT images to assess cardiovascular risk and guide treatment strategies. This tool is best suited for cardiology, radiology, or cardiothoracic surgery departments performing CT scans where detailed calcium scoring, plaque segmentation, and vessel analysis are critical for patient management.
View TeraRecon Cardiovascular.Calcification.CT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-Low EF | TeraRecon Cardiovascular.Calcification.CT |
|---|---|---|
| Deployment | Integrates with current ECG platforms and electronic health records (EHRs). | Cloud-enabled imaging platform. |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Tempus ECG-Low EFTempus ECG-Low EF analyzes 12-lead ECGs and provides a simple binary output (Low LVEF Detected / Not Detected), making it exceptionally straightforward for clinicians to interpret and integrate into existing workflows. In contrast, TeraRecon's solution involves more complex CT image analysis and 3D segmentation, even with 'zero-click' features, requiring a more involved workflow.
Clinical Value
TeraRecon Cardiovascular.Calcification.CTWhile Tempus ECG-Low EF offers valuable early detection of heart failure risk from ECGs, TeraRecon Cardiovascular.Calcification.CT provides a broader and deeper suite of quantitative analyses. Its ability to automatically detect and measure calcifications, perform vessel and cardiac structure segmentation, and support various scoring systems offers comprehensive data for advanced diagnostic and interventional planning.
Pricing & Value
TeraRecon Cardiovascular.Calcification.CTTeraRecon Cardiovascular.Calcification.CT offers a transparent, subscription-based pricing model with a single annual fee, providing operational budget flexibility. In contrast, Tempus ECG-Low EF's pricing is listed as 'contact vendor,' which lacks transparency and predictability for healthcare organizations.
Enterprise Readiness
TeraRecon Cardiovascular.Calcification.CTBoth tools are FDA-cleared, HIPAA compliant, and offer BAA. However, TeraRecon's solution is available as a containerized application or SaaS within its Eureka Clinical AI platform, which is a vendor-agnostic platform designed for integrating and managing multiple AI algorithms, offering greater deployment flexibility and a more comprehensive ecosystem for enterprise integration.
Innovation
TeraRecon Cardiovascular.Calcification.CTTempus ECG-Low EF is innovative in applying AI to widely available ECGs for LVEF detection. However, TeraRecon's solution demonstrates a broader and deeper level of innovation through automatic 3D segmentation, 'zero-click centerline creation,' and comprehensive cardiac analysis features, pushing the boundaries of automated complex medical image analysis.
Support & Docs
TeraRecon Cardiovascular.Calcification.CTTeraRecon provides a dedicated 'User Manuals' page on its website with downloadable electronic user manuals for its products, including Cardiovascular.Calcification.CT, and offers clear customer service contact details, including phone and email, and a 24-hour emergency number. While Tempus provides 'Instructions for Use' and general support contact information, TeraRecon's support structure appears more explicitly detailed and accessible.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-Low EF | TeraRecon Cardiovascular.Calcification.CT |
|---|---|---|
| Name | Tempus ECG-Low EF | TeraRecon Cardiovascular.Calcification.CT |
| Company | Tempus AI | Terarecon |
| Description | FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF ≤40%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation. | AI-powered software as a medical device (SaMD) that analyzes CT images to automatically detect and measure calcifications in the coronary arteries, providing a mask for calcium scoring systems. |
| Key Functionality | AI-powered algorithm for ECG analysis; Detects signs of low Left Ventricular Ejection Fraction (LVEF ≤40%); Analyzes resting, non-ambulatory 12-lead ECG recordings; Provides a binary output (Low LVEF Detected / Not Detected); Aids in identifying patients 40+ years at risk of heart failure | Automatic 3D segmentation of calcified plaques in coronary arteries; Outputs mask for calcium scoring systems; Supports Agatston score, volume, mean mass (mg) measurements; Part of CT Cardiac package with zero-click centerline creation |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and TeraRecon Cardiovascular.Calcification.CT.
Frequently Asked Questions
More Comparisons
More matchups featuring Tempus ECG-Low EF or TeraRecon Cardiovascular.Calcification.CT
Backers
Who funded each tool's parent company.